Synopsis

Source of validity: Scientific
Rating (out of 5): 3

7,4-Dimethoxyflavone is a synthetic derivative of flavones, and its use to support the GABAergic system is primarily based on emerging scientific research rather than tradition. Several in vitro and animal studies have shown that 7,4-Dimethoxyflavone acts as a positive allosteric modulator of GABA_A receptors, the primary inhibitory neurotransmitter system in the brain. For example, a 2014 study by Hanrahan et al. in “Bioorganic & Medicinal Chemistry” found that 7,4-Dimethoxyflavone enhanced GABA-induced currents in recombinant human GABA_A receptors expressed in Xenopus oocytes, suggesting a direct interaction with these receptors. Additional research by the same group and others has demonstrated anxiolytic-like effects in animal models, consistent with GABAergic modulation.

However, human studies are lacking, and the clinical relevance of these findings has not been established. The evidence supporting its use is therefore moderate, reflecting promising preclinical data but an absence of robust clinical trials. There is no record of traditional medicinal use of this compound for GABA-related effects, and its role is not established outside of experimental settings. In summary, while 7,4-Dimethoxyflavone shows scientifically plausible GABAergic activity in preclinical studies, more research is needed to confirm its safety and efficacy in humans.

More about 7,4-Dimethoxyflavone
More about GABA

Other ingredients that support GABA

Other body systems supported by 7,4-Dimethoxyflavone

Products containing 7,4-Dimethoxyflavone